Effect of 2nd Gen TKI in CML
Condition(s):Myeloid Leukemia, ChronicLast Updated:February 20, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Myeloid Leukemia, ChronicLast Updated:February 20, 2024Completed
Condition(s):Leukemia, Myeloid, Chronic-Phase (CML-CP)Last Updated:September 30, 2016Completed
Condition(s):EGFR Positive Non-small Cell Lung CancerLast Updated:November 22, 2023Completed
Condition(s):Lung CancerLast Updated:December 23, 2020Completed
Condition(s):NSCLCLast Updated:October 20, 2020Unknown status
Condition(s):NSCLCLast Updated:June 18, 2021Unknown status
Condition(s):Non-small Cell Lung Cancer; EGFR Gene Mutation; EGFR-TKI Resistant MutationLast Updated:October 6, 2023Not yet recruiting
Condition(s):Carcinoma; Non-Small-Cell LungLast Updated:March 8, 2024Active, not recruiting
Condition(s):Chronic Myeloid LeukaemiaLast Updated:January 12, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:March 6, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.